7 High Yield Dividend Stocks Under $50: Income Investing on a Budget
You don't need $500 per share to build a dividend income portfolio.
Some of the best dividend-paying stocks on the market trade for under $50 ā affordable enough that you can build a diversified income portfolio even with a few thousand dollars. And when you combine a high dividend yield with a low stock price, the compounding math gets very interesting very fast.
But here's the catch: high yields can be traps. A stock yielding 8% sounds amazing until you realize the price dropped 40% because the company might cut the dividend. That's not income investing ā that's catching a falling knife.
That's why we screen every pick using Benjamin Graham's value criteria. We want stocks that are cheap and safe ā high yields backed by strong earnings, manageable debt, and sustainable payout ratios.
Here are 7 high yield dividend stocks under $50 that pass our tests.
Our Screening Criteria
Every stock on this list must meet these requirements:
ā Stock price under $50 ā accessible for everyday investors ā Dividend yield above 4% ā meaningful income ā Payout ratio below 80% ā room to maintain and grow the dividend ā P/E ratio below 15 ā not overvalued by Graham standards ā Positive free cash flow ā the company generates real cash ā At least 3 years of consecutive dividend payments ā no flash-in-the-pan dividends ā Debt-to-equity below 2.0 ā not drowning in leverage
The 7 Picks
1. Pfizer (PFE) ā Yield: ~6.5%
| Metric | Value |
|---|---|
| Stock Price | ~$26 |
| Dividend | $1.72/share annually |
| Yield | ~6.5% |
| P/E Ratio | ~9x |
| Payout Ratio | ~60% |
| Consecutive Dividend Years | 15+ |
Pfizer has been one of the most hated stocks on Wall Street since COVID vaccine revenue dried up. And that's exactly why it's interesting.
The bull case: Pfizer's pipeline is loaded. The oncology portfolio (from the $43 billion Seagen acquisition) is starting to generate meaningful revenue. Weight-loss drug candidates are in clinical trials. And the base business ā with blockbusters like Eliquis, Ibrance, and Prevnar ā still throws off massive cash flow.
The value case: At ~9x earnings, Pfizer is priced like it's going out of business. It's not. The company generates $10+ billion in annual free cash flow, more than enough to cover the $9 billion dividend bill. The payout ratio of ~60% gives breathing room.
Risk: If the pipeline disappoints, the stock could stay in the penalty box. But at this price and yield, a lot of bad news is already priced in.
Graham check: At a P/E of 9x and yield of 6.5%, Pfizer passes every Graham screen we apply. Use our Graham Number Calculator to verify.
2. Ford Motor Company (F) ā Yield: ~5.5%
| Metric | Value |
|---|---|
| Stock Price | ~$10 |
| Dividend | $0.60/share annually |
| Yield | ~5.5% |
| P/E Ratio | ~11x |
| Payout Ratio | ~45% |
| Consecutive Dividend Years | 3+ (reinstated 2023) |
Ford is the ultimate "poor man's stock" ā trading around $10 per share, yielding 5.5%, and building some of the most popular vehicles in America. The F-150 has been the best-selling vehicle in the U.S. for over 40 years.
The bull case: Ford's Pro division (commercial vehicles and fleet services) is a profit engine with recurring revenue from software subscriptions and telematics. The traditional gas-powered truck and SUV business is highly profitable. Ford is also being more disciplined with its EV spending after pulling back from unprofitable launches.
The value case: At ~$10 per share, you're paying 11x earnings for a company generating $7-8 billion in adjusted free cash flow. The dividend consumes less than half of free cash flow, making it well-covered.
Risk: The auto industry is cyclical. A recession would hurt sales. EV investments remain a drag on profitability. But at $10 and a 5.5% yield, the bar is low.
3. AT&T (T) ā Yield: ~5.0%
| Metric | Value |
|---|---|
| Stock Price | ~$28 |
| Dividend | $1.39/share annually |
| Yield | ~5.0% |
| P/E Ratio | ~10x |
| Payout Ratio | ~50% |
| Consecutive Dividend Years | 3+ (post-cut) |
AT&T cut its dividend in 2022 when it spun off WarnerMedia, and many income investors fled. Their loss, your gain.
The bull case: The "new" AT&T is a focused telecom company with improving metrics. Fiber broadband subscribers are growing rapidly (8+ million, targeting 30 million passings). 5G subscriber additions are strong. And without the media business dragging it down, free cash flow is dramatically improved ā over $16 billion annually.
The value case: AT&T trades at roughly 10x earnings with a well-covered 5% yield. The company is aggressively paying down debt ā reducing net debt by $20+ billion since the WarnerMedia spin. The balance sheet is healing fast.
Risk: Heavy capital expenditure requirements (5G and fiber buildout). But AT&T has committed to maintaining the current dividend and reducing debt, and free cash flow supports both.
4. Realty Income (O) ā Yield: ~5.5%
| Metric | Value |
|---|---|
| Stock Price | ~$50 |
| Dividend | $3.10/share annually |
| Yield | ~5.5% |
| P/FFO Ratio | ~13x |
| Payout Ratio | ~75% (of FFO) |
| Consecutive Dividend Increases | 30+ years |
Realty Income calls itself "The Monthly Dividend Company" ā and it delivers. This REIT pays dividends every single month and has increased its payout for over 30 consecutive years. It's a Dividend Aristocrat (S&P 500 companies with 25+ years of consecutive dividend increases).
The bull case: Realty Income owns 15,400+ properties leased to tenants like Walgreens, Dollar General, 7-Eleven, and FedEx on long-term, net-lease contracts. Tenants pay rent plus property taxes, insurance, and maintenance ā so Realty Income's costs are minimal.
The value case: REITs should be valued on Price-to-FFO (Funds From Operations) rather than P/E. At ~13x FFO, Realty Income is trading at its cheapest valuation in years, pushed down by rising interest rates.
Risk: Higher interest rates increase borrowing costs for REITs. But Realty Income has investment-grade credit, 98%+ occupancy, and well-staggered debt maturities.
5. Verizon Communications (VZ) ā Yield: ~6.4%
| Metric | Value |
|---|---|
| Stock Price | ~$42 |
| Dividend | $2.71/share annually |
| Yield | ~6.4% |
| P/E Ratio | ~9x |
| Payout Ratio | ~55% |
| Consecutive Dividend Increases | 20+ years |
Verizon is the highest-yielding Dow Jones stock and one of the best income plays in the market. The company has raised its dividend for 20 consecutive years with no signs of stopping.
The bull case: The 5G buildout is essentially complete, meaning capital expenditure is declining while revenue benefits persist. Verizon's wireless business is a cash machine ā 95%+ of revenue comes from recurring subscriptions. Fixed wireless broadband (using 5G for home internet) is a growth lever with 4+ million subscribers and growing.
The value case: At ~9x earnings, Verizon is priced like a dying business. But wireless communication isn't going anywhere. The 55% payout ratio means the dividend is rock-solid, and free cash flow of $18+ billion annually provides a thick cushion.
Risk: Consumer wireless is a mature market with limited growth. Price competition from T-Mobile is intense. But the yield compensates you handsomely for waiting.
6. Altria Group (MO) ā Yield: ~7.5%
| Metric | Value |
|---|---|
| Stock Price | ~$55 |
| Dividend | $4.08/share annually |
| Yield | ~7.5% |
| P/E Ratio | ~10x |
| Payout Ratio | ~75% |
| Consecutive Dividend Increases | 55+ years |
Note: Altria recently crossed above $50 and may fluctuate around that threshold. We include it because it frequently trades in the $48-55 range and represents one of the highest-yielding blue chips available.
Altria is the most controversial stock on this list. It sells Marlboro cigarettes, the world's best-known tobacco brand. Many investors won't touch it for ethical reasons ā and that's exactly why the yield is so high.
The bull case: Cigarette volumes decline ~4% per year, but Altria raises prices to more than offset volume declines. Revenue and earnings have been remarkably stable for decades. The NJOY e-cigarette brand (now FDA-authorized) provides a bridge to the future. And 55 consecutive years of dividend increases make it one of the longest streaks in the market ā a Dividend King.
The value case: At 10x earnings with a 7.5% yield, Altria is a cash flow machine. The company generates enough free cash flow to cover the dividend and buy back shares, providing double-barreled shareholder returns.
Risk: Regulatory risk (FDA could mandate nicotine reduction). Volume declines could accelerate. ESG-focused funds are divesting. But the company has navigated 60+ years of regulatory headwinds and kept growing dividends.
7. KeyCorp (KEY) ā Yield: ~5.0%
| Metric | Value |
|---|---|
| Stock Price | ~$17 |
| Dividend | $0.83/share annually |
| Yield | ~5.0% |
| P/E Ratio | ~11x |
| Payout Ratio | ~55% |
| Consecutive Dividend Years | 10+ |
Regional banks are unloved after the 2023 banking crisis (SVB, First Republic). But KeyCorp survived, stabilized, and now trades at a steep discount to book value.
The bull case: KeyCorp is one of the largest regional banks in the U.S. with $190+ billion in assets. It has a strong commercial banking franchise, investment management business, and consumer lending operation. The bank secured a strategic investment from Scotiabank (Bank of Nova Scotia) in 2024, providing a capital boost and international partnership.
The value case: At ~11x earnings and 0.9x book value, KeyCorp is trading below what its assets are worth on paper. The 5% yield is well-covered by a 55% payout ratio. Net interest income should improve as the yield curve normalizes.
Risk: Regional bank sentiment remains fragile. Commercial real estate exposure is a concern for the entire sector. But at these valuations, a lot of risk is already priced in.
Building a Portfolio: The $5,000 Starter
Here's how you could allocate $5,000 across these seven stocks:
| Stock | Allocation | Amount | Annual Dividend |
|---|---|---|---|
| PFE | 15% | $750 | ~$49 |
| F | 15% | $750 | ~$41 |
| T | 15% | $750 | ~$38 |
| O | 15% | $750 | ~$41 |
| VZ | 15% | $750 | ~$48 |
| MO | 10% | $500 | ~$38 |
| KEY | 15% | $750 | ~$38 |
| Total | 100% | $5,000 | ~$293/year |
That's approximately $293 per year in dividends from a $5,000 investment ā a blended yield of about 5.9%.
Reinvest those dividends through a DRIP (dividend reinvestment plan), and the compounding kicks in. After 20 years at a 5.9% yield with reinvested dividends (and assuming zero price appreciation), your $5,000 grows to approximately $15,800. With even modest price appreciation, it's considerably more.
Warning Signs: When a High Yield Is a Trap
Not every high-yield stock is a good investment. Watch for these red flags:
š© Payout ratio above 100% ā The company is paying more in dividends than it earns. The cut is coming.
š© Declining revenue and earnings ā A high yield caused by a falling stock price, not a high dividend.
š© Excessive debt ā Companies borrowing to pay dividends are living on borrowed time (literally).
š© One-time special dividends inflating the yield ā Look at the regular quarterly payment, not special distributions.
š© The yield is astronomically high (10%+) ā Yields that high almost always signal distress. The market is telling you something.
The Bottom Line
High yield dividend stocks under $50 exist ā and they can form the foundation of a serious income portfolio. The key is separating sustainable yields from dividend traps.
Use Graham's criteria: low P/E, reasonable payout ratio, positive free cash flow, and manageable debt. If a stock passes these tests and yields 4%+ at an affordable price, it deserves a closer look.
Start by running these stocks through our Graham Number Calculator to see which ones trade below their intrinsic value. Then build a diversified basket ā don't put all your money into one high-yielder, no matter how safe it looks.
Ready for more value picks? Join our free newsletter for weekly dividend stock analysis and value investing insights delivered to your inbox.
The information on this site is for educational purposes only. Poor Man's Stocks does not provide financial advice, and nothing here should be interpreted as a recommendation to buy or sell any security. Always do your own research and consult a licensed financial advisor before making investment decisions.
Get Picks Like This Every Tuesday
Join 10,000+ value investors getting our best undervalued stock picks, Graham Number breakdowns, and dividend analysis ā free.
Get Our Best Stock Picks ā Free
Join 10,000+ value investors. Get our top undervalued stock picks, Graham-style analysis, and dividend recommendations delivered to your inbox every week.
No spam, ever. Unsubscribe anytime.